XTAI
1817
Market cap90mUSD
Oct 08, Last price
39.70TWD
1D
0.00%
1Q
2.45%
Jan 2017
6.15%
IPO
44.52%
Name
Sanitar Co Ltd
Chart & performance
P/E
10.94
P/S
1.10
EPS
3.63
Div yield, %
6.05%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
2.57%
Revenues
2.62b
-6.17%
Net income
263m
-16.42%
CFO
467m
+51.08%
Dividend
Jun 30, 20262.2 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sanitar Co., Ltd. is a Taiwanese enterprise dedicated to the production and global distribution of porcelain sanitary items, supplying both local and international markets. The company boasts an extensive inventory of bathroom essentials, which encompasses various toilets, washbasins, pedestals, and urinals. Their offerings also include a diverse range of faucets and shower systems, sophisticated electronic bidet seats, mirrors, and other complementary sanitary accessories, in addition to brass fittings for water supply applications. Furthermore, Sanitar Co., Ltd. provides management-related services. Founded in 1985, the company maintains its headquarters in New Taipei City, Taiwan. It operated under the name Sanken Industrial Co., Ltd. until 2003 when it officially rebranded as Sanitar Co., Ltd.
Key people
Yu Chuan Chen
Chief Financial Officer · since 2023
Fenggui Gu
Chief Operating Officer-Business Division · since 2008
Wei Chih Chen
General Manager, Corporate Governance Officer · since 2025
Rongren Huang
Deputy General Manager - Administration Division · since 2024
Zhaozhi Chen
Head of Accounting · since 2024
Mingxi Cai
Director
Guohua Lin
Director · since 2021
Junxiang Xiao
Chairman of the Board · since 2016
Yixin Zhang
Director · since 2024
Xianjian Chen
Independent Director · since 2021
Independent Director · since 2021
Zhengwei He
Independent Director · since 2021
Jing Lin
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||